Company & Sponsor Intelligence
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting1
Completed4
Countries1
Therapeutic footprint
dementia_otherdepressionepilepsypain_neuropathyschizophrenia
Indexed studies
NCT01669967The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin
pain_neuropathy · CanadaNA
pain_neuropathy · CanadaNA
NCT04020484Making Mindfulness Matter© in Children With Epilepsy
epilepsy · CanadaNA
epilepsy · CanadaNA
NCT04747379Psychological Effect of Explicit Recall After Sedation (PEERS)
depression · CanadaCOMPLETED
depression · CanadaCOMPLETED
NCT02945774Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias
dementia_other · CanadaNA
dementia_other · CanadaNA
NCT00480168A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics
schizophrenia · CanadaCOMPLETED
schizophrenia · CanadaCOMPLETED
NCT03086980Automatic Self Transcending Meditation (ASTM) Versus Usual Care in Patients With Glaucoma
depression · CanadaNA
depression · CanadaNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →